ライフサイエンス出版株式会社

FacebookTwitterInstagram
menu

Japan Society of Clinical Trials and Research ( JPT Supplement )

Vol. 40 Suppl. 2 2012

■Symposium 1:How to Conduct International Collaboration Clinical Study in Oncology

Where Japan Clinical Oncology Group (JCOG) Has Been and Where JCOG Is Going

H. Fukuda

Jpn Pharmacol Ther 2012 40(s2) s90-3


The Establishment of West Japan Oncology Group (WJOG),and Current Situation and Prospect of It

S. Nakamura

Jpn Pharmacol Ther 2012 40(s2) s94-7


The Past and Future of Investigator-Initiated Clinical Trials Conducted by Japanese Gynecologic Oncology Group (JGOG)

K. Ochiai

Jpn Pharmacol Ther 2012 40(s2) s98-101


The Past and Future of Japan Adult Leukemia Study Group (JALSG)

T. Naoe

Jpn Pharmacol Ther 2012 40(s2) s102-5


The Current Status and Issues of Comprehensive Support Project for Oncology Research-Breast Cancer

H. Mukai

Jpn Pharmacol Ther 2012 40(s2) s106-8

Symposium 2: Data Management: Clinical Trials and Current Topics

Clinical Trial and ICH Harmonized Tripartite Guideline: From the Point of Structure and Content of Clinical Study Reports E3

H. Sakai, et al.

Jpn Pharmacol Ther 2012 40(s2) s109-12


Enhancing Drug Safety Evaluation: from "Formality" to "Science" 

O. Komiyama

Jpn Pharmacol Ther 2012 40(s2) s113-5

■REPORT

Report from Subgroup Education, Training, Infrastructure and Patient Involvement under OECD GSF Working Group to Facilitate International Cooperation in Non-Commercial Clinical Trials freetext

Øyvind Melien, et al.

Jpn Pharmacol Ther 2012 40(s2) s137-82